Literature DB >> 17582453

Differential functional phenotypes of two primary HIV-1 strains resulting from homologous point mutations in the LLP domains of the envelope gp41 intracytoplasmic domain.

Jason T Newman1, Timothy J Sturgeon, Phalguni Gupta, Ronald C Montelaro.   

Abstract

We previously reported that selected mutations of highly conserved arginine residues within the LLP regions of HIV-1(ME46) gp41 had diverse effects on Env function. In the current study, we sought to test if the observed LLP mutant phenotypes would be similar in HIV-1(89.6). The results of the current studies revealed that the LLP-1 mutations conferred reduced Env incorporation, infectivity, and replication phenotypes in both viruses, while homologous LLP-2 mutations had differential phenotypical effects between the two strains. In particular, several of the 89.6 LLP-2 mutant viruses were replication defective in CEMX174 cells despite having increased levels of Env incorporation, and with both strains, there were differential effects on infectivity. This comparison of homologous point mutations in two different strains of HIV supports the role of LLPs as determinants of Env function, but reveals for the first time the influence of virus strain on LLP mutant phenotypes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17582453      PMCID: PMC2034414          DOI: 10.1016/j.virol.2007.05.027

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  90 in total

1.  Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251.

Authors:  Barbara L Shacklett; Karen E S Shaw; Lou A Adamson; David T Wilkens; Catherine A Cox; David C Montefiori; Murray B Gardner; Pierre Sonigo; Paul A Luciw
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity.

Authors:  John R Day; Carsten Münk; John C Guatelli
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

3.  Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity.

Authors:  Eloísa Yuste; Jacqueline D Reeves; Robert W Doms; Ronald C Desrosiers
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

Authors:  R D Salter; D N Howell; P Cresswell
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

5.  Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation.

Authors:  Vandana Kalia; Surojit Sarkar; Phalguni Gupta; Ronald C Montelaro
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion.

Authors:  S Matthew Cleveland; Lesley McLain; Linda Cheung; Tim D Jones; Mark Hollier; Nigel J Dimmock
Journal:  J Gen Virol       Date:  2003-03       Impact factor: 3.891

7.  Targeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for env incorporation into virions and infectivity.

Authors:  Guillaume Blot; Katy Janvier; Sophie Le Panse; Richard Benarous; Clarisse Berlioz-Torrent
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail.

Authors:  Donald J Wyma; Jiyang Jiang; Jiong Shi; Jing Zhou; Janet E Lineberger; Michael D Miller; Christopher Aiken
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity.

Authors:  Tsutomu Murakami; Sherimay Ablan; Eric O Freed; Yuetsu Tanaka
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  A novel monoclonal antibody specific to the C-terminal tail of the gp41 envelope transmembrane protein of human immunodeficiency virus type 1 that preferentially neutralizes virus after it has attached to the target cell and inhibits the production of infectious progeny.

Authors:  Steven A Reading; Caroline J Heap; Nigel J Dimmock
Journal:  Virology       Date:  2003-10-25       Impact factor: 3.616

View more
  9 in total

1.  Highly conserved structural properties of the C-terminal tail of HIV-1 gp41 protein despite substantial sequence variation among diverse clades: implications for functions in viral replication.

Authors:  Jonathan D Steckbeck; Jodi K Craigo; Christopher O Barnes; Ronald C Montelaro
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

2.  HIV-1 Cell-Free and Cell-to-Cell Infections Are Differentially Regulated by Distinct Determinants in the Env gp41 Cytoplasmic Tail.

Authors:  Natasha D Durham; Benjamin K Chen
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

3.  Functional and structural segregation of overlapping helices in HIV-1.

Authors:  Maliheh Safari; Bhargavi Jayaraman; Shumin Yang; Cynthia Smith; Jason D Fernandes; Alan D Frankel
Journal:  Elife       Date:  2022-05-05       Impact factor: 8.713

4.  Matrix and envelope coevolution revealed in a patient monitored since primary infection with human immunodeficiency virus type 1.

Authors:  Elodie Beaumont; Daniela Vendrame; Bernard Verrier; Emmanuelle Roch; François Biron; Françis Barin; Fabrizio Mammano; Denys Brand
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

5.  4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response.

Authors:  Elin S Gray; Penny L Moore; Frederic Bibollet-Ruche; Hui Li; Julie M Decker; Tammy Meyers; George M Shaw; Lynn Morris
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

6.  Unique functional properties of conserved arginine residues in the lentivirus lytic peptide domains of the C-terminal tail of HIV-1 gp41.

Authors:  Anne-Sophie Kuhlmann; Jonathan D Steckbeck; Timothy J Sturgeon; Jodi K Craigo; Ronald C Montelaro
Journal:  J Biol Chem       Date:  2014-02-04       Impact factor: 5.157

7.  Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection.

Authors:  Gama P Bandawe; Darren P Martin; Florette Treurnicht; Koleka Mlisana; Salim S Abdool Karim; Carolyn Williamson
Journal:  Virol J       Date:  2008-11-24       Impact factor: 4.099

8.  HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses.

Authors:  Alexis Kafando; Christine Martineau; Mohamed El-Far; Eric Fournier; Florence Doualla-Bell; Bouchra Serhir; Adama Kazienga; Mohamed Ndongo Sangaré; Mohamed Sylla; Annie Chamberland; Hugues Charest; Cécile L Tremblay
Journal:  Viruses       Date:  2019-11-01       Impact factor: 5.048

9.  Study of the HIV-2 Env cytoplasmic tail variability and its impact on Tat, Rev and Nef.

Authors:  Nordine Bakouche; Anne-Thérèse Vandenbroucke; Patrick Goubau; Jean Ruelle
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.